I have previously written about whether thrombosis (formation of blood clots) is linked to the AstraZeneca COVID-19 vaccine – my conclusion was that they probably weren’t. But still, there are nagging anecdotes and government decisions that may concern those of you who are looking to get the vaccine.
Recently, the government of Quebec recently decided that the AstraZeneca vaccine will only be used on individuals 55 years and older. Of course, this caused some parts of the anti-vaccine world to froth at the mouth claiming the vaccine isn’t safe.
I think that many of the adverse events that are claimed to be associated with any of the COVID-19 vaccines involve the post hoc ergo propter hoc fallacy, which states that because one event precedes another event, they must be linked. It is entirely possible that thrombosis occurs after vaccinations because of random chance rather than actual correlation (let alone causation).
Because the AstraZeneca COVID-19 vaccine is one of the four main vaccines (along with those from Pfizer, Moderna, and JNJ) to be given in the USA, Canada, the EU, Australia, and New Zealand, I want to make sure that the potential of a causal link to thrombosis events are given a thorough analysis. I especially want to focus on why the Government of Quebec decided to make this change – and it’s a lot more complicated than the narratives pushed by the anti-vaccine crowd.Continue reading “AstraZeneca COVID-19 vaccine and thrombosis – should we worry?”